CD8A and neoplasm: Effector T cells (CTL), which play a crucial role in anti-tumor immune responses, differentiate and proliferate from naive CD8+ T cells via stimulation from IL-2 produced by CD4+ T cells presented with cancer antigens by dendritic cells.